Table 5

Frequency of FFLL and FfLL genotypes versus all other FokI and poly(A) combinations in controls and cancer patients with and without metastases

FFLL or FfLLAll other FokI/poly(A) combinationsTotalOdds ratio (95% CI)Odds ratio* (95% CI)Odds ratio (95% CI)
Control1093184271.001.001.00
Cancer patients (no metastases)1262143401.72 (1.26–2.34)1.87 (1.34–2.61)2.01 (1.43–2.84)
Cancer patients (with metastases)2731582.54 (1.45–4.45)3.07 (1.70–5.54)3.35 (1.82–6.16)
  • * Adjusted odds ratio for age (of controls at sampling and cases at diagnosis), HRT usage, and menopausal status.

  • Adjusted odds ratio for age (of controls at sampling and cases at sampling), HRT usage, and menopausal status.

  • P < 0.001.